Infection risk high in polymyalgia rheumatica and giant cell arteritis, plus more new findings

In this sideshow, we highlight recent advances in polymyalgia rheumatica and giant cell arteris, two conditions that often go hand-in-hand. In one study we feature, researchers report that cardiovascular risk factors may increase the risk of polymyalgia rheumatica and giant cell arteritis. Other reports include: Patients with polymyalgia rheumatica (PMR) are often prescribed long-term glucocorticoid therapy, despite the risk of osteoporosis. Infection risk high in PMR and GCA cases associated with oral glucocorticoids. Common biomarkers in PMR and GCA. Vitamin D may play a role in autoimmune conditions.RELATED: Pitfalls Associated with Diagnosing Polymyalgia Rheumatica and Fibromyalgia in Young Obese Patients EULAR/ACR Treatment Guidelines for Polymyalgia Rheumatica